Device Trial Radar · NCT05026658
Prospective, Randomized, Controlled Agreement and Reproducibility Clinical Study
Last checked: Nov 19, 2026Latest source record: Nov 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
358
Actual
Start
Jul 22, 2021
Primary completion
Oct 4, 2021
Study completion Oct 4, 2021
Sponsor
- Lead sponsor
- VisiblyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 30, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Visual acuity is the relative ability of the eye to resolve detail that is usually expressed as the reciprocal of the minimum angular separation in minutes of two lines just resolvable as separate and that forms in the average human eye an angle of one minute. Visibly Inc. has developed a method for determining a patient's visual acuity electronically via a web-based software system that can be self-administered wherever convenient. This method provides an efficient alternative for people to have immediate access to visual acuity measurements.
Conditions
- Digital Acuity Product
Interventions
Visibly Digital Acuity ProductDevice
The order of testing (two VDAP home environments and ETDRS) will be randomly assigned for each subject as one of four sequences: 1. V1, E, V2 2. E, V1, V2 3. V2, E, V1 4. E, V2, V1 Where E denotes the ETDRS assessment, V1 denotes the VDAP assessment in home environment 1, and V2 denotes the VDAP assessment in home environment 2. The randomization will be blocked in groups of 4 subjects to ensure balance for the VA testing sequences.
Primary outcomes
What the sponsor says the trial is designed to measure.
- EffectivenessTime frame: Up to 3 hours
- ReproducibilityTime frame: Up to 3 hours
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Andover Eye Associates
Andover, Massachusetts
Core, Inc
Shelby, North Carolina
Total Eye Care
Memphis, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.